Tirzepatide is a single peptide that acts as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. It is investigated in research models for its interactions with incretin signalling, glucose homeostasis, and energy-balance pathways.
- Dual GLP-1 / GIP receptor agonism
- Studied in metabolic, incretin, and satiety research
- HPLC-verified, lyophilised powder for reconstitution
Supplied strictly for laboratory research purposes only. Not for human consumption, medical use, or veterinary application. Not approved by the MHRA. By purchasing, you confirm use in a qualified research environment.
Reviews
There are no reviews yet.